|
2011
|
Invention
|
Diaryl-substituted five-membered heterocycle derivative.
The present invention provides the comp... |
|
2010
|
Invention
|
Inhibitors of akt activity. The instant invention provides for substituted thiazoles that inhibit... |
|
2009
|
Invention
|
Methods for prediction of rb status and sensitivity to plk1 inhibitor of cell. Disclosed is a met... |
|
|
Invention
|
5/5-or 5/6-membered condensed ring cycloalkylamine derivative.
Disclosed are a compound of a for... |
|
|
Invention
|
Novel spirochromanone carboxylic acids. The invention relates to a compound of a general formula ... |
|
|
Invention
|
Spirodiamine-diarylketoxime derivative. Disclosed is a melanin-concentrating hormone receptor ant... |
|
|
Invention
|
Process for producing bicycloaniline derivatives. The present invention relates to a process for ... |
|
|
Invention
|
Novel isoxazole drivative.
Disclosed is a compound represented by formula (I) or a pharmaceutica... |
|
|
Invention
|
Novel isoxazole derivative. Disclosed is a compound represented by formula (I) or a pharmaceutica... |
|
|
Invention
|
Inhibitors of akt activity. The instant invention provides for substituted naphthyridine compound... |
|
|
Invention
|
Inhibitors of akt activity. The instant invention provides for substituted [1,2,4]triazolo[4,3-a]... |
|
|
Invention
|
Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active in... |
|
|
Invention
|
Method for screening of pharmaceutical candidate substance for treatment of cancer in which hedge... |
|
|
Invention
|
Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone recept... |
|
|
Invention
|
Alkylaminopyridine derivative.
The present invention relates to a compound that is useful for tr... |
|
|
Invention
|
Alkylaminopyridine derivative. Disclosed is a compound represented by formula (I) or a pharmaceut... |
|
|
Invention
|
Novel aminopyridine derivatives having aurora a selective inhibitory action. The present inventio... |
|
|
Invention
|
3-substituted sulfonyl piperazine derivative. Disclosed is a compound which is useful as a prophy... |
|
2008
|
Invention
|
Sulfonyl substituted 6-membered ring derivative. A compound that is useful as an agent in the pre... |
|
|
Invention
|
N-pyrazole-2-pyridinecarboxamide derivative. Disclosed is a compound represented by the formula (... |
|
|
Invention
|
Heteroaryloxy quinazoline derivative. Disclosed is a compound represented by the formula (I) belo... |
|
|
Invention
|
Pyridone-substituted-dihydropyrazolopyrimidinone derivative. Disclosed are: a compound represente... |
|
|
Invention
|
Benzoxazinone derivative. [PROBLEMS] To provide a compound useful as an agent for the treatment o... |
|
|
Invention
|
Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor... |
|
|
Invention
|
Method for producing pyrazol-3-yl-benzamide derivative. Disclosed is a method for commercially pr... |
|
|
Invention
|
4-sulfonylpiperidine derivatives. [PROBLEMS] To provide compounds useful as prophylatic or therap... |
|
|
Invention
|
Bicycloaniline derivative. Disclosed are: a compound represented by the general formula (I); and ... |
|
|
Invention
|
Polymorph of dihydropyrazolopyrimidinone derivative as weel kinase.inhibitor. The present inventi... |
|
|
Invention
|
Indoledione derivative. A compound represented by the general formula (I-a): (I-a) [wherein R1a a... |
|
|
Invention
|
Method for predicting a drug transport capability by abcg2 polymorphisms.
The present invention ... |
|
|
Invention
|
Substituted spirochromanone derivatives as acc inhibitors. The invention relates to a compound of... |
|
|
Invention
|
Spirochromanon derivatives. The invention relates to a compound of a general formula (I): wherein... |
|
2007
|
Invention
|
Novel aminopyrimidine derivative as plk1 inhibitor. Disclosed is a compound represented by the ge... |
|
|
Invention
|
Novel aminopyrimidine derivatives as plk1 inhibitors. The present invention relates to a compound... |
|
|
Invention
|
Aminopyrimidine derivatives as plk1 inhibitors. The present invention relates to a compound repre... |
|
|
Invention
|
Animal having modification in mgat2 gene. [PROBLEMS] To provide: a gene-modified non-human animal... |
|
|
Invention
|
Method for evaluating compound acting on mark4. It is intended to find a kinase whose expression ... |
|
|
Invention
|
Novel phenyl-isoxazol-3-ol derivative. Disclosed is a compound represented by the formula (I) bel... |
|
|
Invention
|
2-pyridinecarboxamide derivative having gk-activating activity. Disclosed is a compound represent... |
|
|
Invention
|
Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor... |
|
|
Invention
|
Diaryl ketimine derivative. Disclosed is a compound represented by the following formula (I). [ch... |
|
|
Invention
|
Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction.
The... |
|
2006
|
Invention
|
Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea.
An NPY Y2 agoni... |
|
|
Invention
|
Method for evaluating compound using barlp and substance for regulating eating and body weight.
... |
|
|
Invention
|
Method of measuring enzyme activity and method of evaluating compound.
It is intended to provide... |
|
|
Invention
|
Method for detecting p53 dysfunction, method for molecular diagnosis of cancer and method for eva... |
|
2005
|
Invention
|
Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and... |
|
|
Invention
|
Method of screening compound directly activating glycogen synthase.
The present invention provid... |
